Page last updated: 2024-08-21

indazoles and Chronic Kidney Failure

indazoles has been researched along with Chronic Kidney Failure in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chamberlain, S; Mole, DR; Protheroe, A; Purshouse, K; Soares, M; Tuthill, M1
Jeon, SY; Lee, NR; Yim, CY1
Atkinson, BJ; Flaherty, AL; Jonasch, E; Matrana, MR; Shetty, AV; Tannir, NM1
Bersanelli, M; Buti, S; Facchinetti, F; Maiorana, M; Tiseo, M1
Campistron, G; Conte, JJ; Dueymes, JM; Ego, D; Houin, G; Rovei, V1

Reviews

1 review(s) available for indazoles and Chronic Kidney Failure

ArticleYear
Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report.
    Current drug targets, 2016, Volume: 17, Issue:15

    Topics: Adult; Angiogenesis Inhibitors; Carcinoma, Renal Cell; Dose-Response Relationship, Drug; Half-Life; Humans; Indazoles; Kidney Failure, Chronic; Kidney Neoplasms; Male; Pyrimidines; Renal Dialysis; Sulfonamides; Treatment Outcome

2016

Other Studies

4 other study(ies) available for indazoles and Chronic Kidney Failure

ArticleYear
Case report of oxalate nephropathy in a patient with pancreatic metastases from renal carcinoma.
    BMC cancer, 2019, Oct-17, Volume: 19, Issue:1

    Topics: Acetates; Aged, 80 and over; Calcium Compounds; Carcinoma, Renal Cell; Exocrine Pancreatic Insufficiency; Gastrointestinal Agents; Humans; Indazoles; Kidney Failure, Chronic; Kidney Neoplasms; Male; Oxalates; Pancreatic Neoplasms; Pancrelipase; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis; Sulfonamides; Treatment Outcome

2019
Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
    BMC nephrology, 2019, 01-03, Volume: 20, Issue:1

    Topics: Aged; Amlodipine; Angiogenesis Inhibitors; Antihypertensive Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Combined Modality Therapy; Diabetic Nephropathies; Dihydropyridines; Drug Substitution; Edema; Everolimus; Humans; Hypertension; Indazoles; Kidney Failure, Chronic; Lung Neoplasms; Male; Nephrotic Syndrome; Nivolumab; Pancreatic Neoplasms; Pancreaticoduodenectomy; Pneumonectomy; Protein Kinase Inhibitors; Pyrimidines; Sirolimus; Sulfonamides; Sunitinib

2019
Outcomes of patients with metastatic renal cell carcinoma and end-stage renal disease receiving dialysis and targeted therapies: a single institution experience.
    Clinical genitourinary cancer, 2014, Volume: 12, Issue:5

    Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Disease-Free Survival; Everolimus; Female; Humans; Indazoles; Kidney Failure, Chronic; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis; Retrospective Studies; Sirolimus; Sorafenib; Sulfonamides; Treatment Outcome

2014
Pharmacokinetics of bendazac-lysine and 5-hydroxybendazac in patients with renal insufficiency.
    European journal of clinical pharmacology, 1987, Volume: 33, Issue:3

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Blood Proteins; Female; Humans; Indazoles; Kidney Failure, Chronic; Male; Middle Aged; Protein Binding; Pyrazoles

1987